The key programs get the scrutiny. The rest of the portfolio is approved and left alone.
Large, visible programs get a business case, steering reviews and benefit tracking. The long tail is approved once and rarely revisited, even when hundreds of millions are committed each year.
Cases from different teams are built differently, so comparing them at the funding table takes judgment more than evidence.
BCG's 2026 study of nearly 600 multi-business companies finds that the best capital allocators weigh investment requests against one another, rather than approving each on its own merits. Comparing cases side by side turns a string of go or no-go calls into a real selection. BCG, Aug 2026
In BCG's survey of 152 CEOs, only 14% have clearly defined the P&L impact for all of their AI initiatives. BCG's advice: define the value logic before each initiative launches, with finance validating results from day one. BCG, Jul 2026
Apply one lighter, consistent standard to every case, not only the big ones, so the long tail can be compared at approval and revisited later.